Share
Publications
-
30 July 2009 /Publications - miscellaneous
-
23 July 2009 /Retail and online sale
Annual report on the inspection of retail sale of OTC medicines 2008-2009
In 2008, the Danish Medicines Agency intensified its efforts on removing expired over-the-counter medicine from retail distribution.
-
03 July 2009 /About us
Performance contract 2009
The Danish Medicines Agency and the Ministry of Health and Prevention have agreed upon a performance contract, which is valid for 2009. The contract, which is in Danish only, focuses on external targets that cover the Danish Medicines Agency's tasks to the greatest extent possible.
-
17 June 2009 /Prices and reimbursement
Use of prescription weight-loss products from 2003-2007
In recent years, the number of persons treated with prescription-only weight-loss products has increased, however, the total number of persons receiving treatment is lower than before 2002. The weight-loss products are primarily used by women aged between 35-55. In 2007, the number of users was affected by seasonal variations, which are more pronounced if we exclude persons who at the same time receive other medicines associated with overweight.
-
17 June 2009 /Prices and reimbursement
Sale of liberalised OTC medicines from 2001-2007
The liberalisation of over-the-counter products (OTC medicines) may have contributed to an increase in the sale of smoking cessation products in the period from 2001-2007. With regard to the remaining medicinal products, there is nothing to suggest that the sale in general sales outlets has led to increased consumption.
-
28 May 2009 /Publications - miscellaneous
-
28 April 2009 /Prices and reimbursement
-
17 April 2009 /About us
Danish Medicines Agency annual accounts 2008
In 2008, the Danish Medicines Agency achieved a target performance of 91.9 per cent in respect of the targets set out in the performance contract with the Danish Ministry of Health and Prevention, corresponding to a fulfillment of four in every five sub-requirements. Overall, we find that we delivered good technical results in 2008.
-
16 April 2009 /Authorisation and supervision
Product defects and withdrawal of medicinal products in 2008
In 2008, 177 reports of medicinal product defects were registered, which is less than in 2007. 23 % of these reports led to products being withdrawn from the market, which is also less than in the preceding years. Most of the withdrawals effected in 2008 were occasioned by reports made by the companies.
-
19 December 2008 /About us
-
05 November 2008 /Publications - miscellaneous
-
13 October 2008 /Product areas
Report on the blood product area in 2007
The blood product report is published every year based on figures from the Danish blood centres and the Blood-donors in Denmark.
-
19 September 2008 /Publications - miscellaneous
Survey of pharmaceutical companies' satisfaction with the Danish Medicines Agency
The research company Capacent Epinion has asked pharmaceutical companies to indicate their level of satisfaction with the Danish Medicines Agency. A total of 40 companies participated in the survey, which was carried out in May to June 2008.
-
10 September 2008 /About us
Danish Medicines Agency annual report 2007
The annual report 2007 takes you through important activities within the Danish Medicines Agency in 2007. On a number of theme pages, we also tell about projects that strengthen our cooperation with the business sector, our relations to consumers and our involvement in European development.
-
19 May 2008 /Authorisation and supervision
Product defects and withdrawal of medicinal products in 2007
In 2007, 202 reports about medicinal product defects were registered, which is basically on level with 2006. 28 % of these reports resulted in a withdrawal from the Danish market, which is exactly the same proportion as the year before.
-
22 April 2008 /About us
Danish Medicines Agency annual accounts 2007
In 2007, the Danish Medicines Agency achieved a target performance of 93.9 per cent in respect of the targets set out in the performance contract with the Danish Ministry of Health and Prevention, corresponding to a fulfillment of three in every four sub-requirements. Overall, we assess that we delivered good technical results in 2007, among other things, based on the fact that the most strategically important performance requirements were fulfilled.
-
11 April 2008 /Publications - miscellaneous
-
05 December 2007 /Publications - miscellaneous
-
03 December 2007 /Retail and online sale
-
12 October 2007 /Publications - miscellaneous
Positive evaluation of the Institute for Rational Pharmacotherapy
Since 1999, the Institute for Rational Pharmacotherapy (IRF) has worked to promote rational use of medicinal products in Denmark. In 2005, an external evaluation of IRF was commissioned by the Danish Medicines Agency, the aim of which was to investigate IRF's reputation and credibility among its primary target group (general practitioners) and other relevant groups. The enclosed reports is a result of this evaluation.
